Clinical trials
Recruiting Phase 3 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2024 | 3 |
| 2025 | 4 |
| 2026 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| GlaxoSmithKline | 4 |
| 89bio, Inc. | 2 |
| Akero Therapeutics, Inc | 1 |
| Eli Lilly and Company | 1 |
| Haisco Pharmaceutical Group Co., Ltd. | 1 |
| King's College London | 1 |
| National Taiwan University Hospital | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 11 |
| Fatty Liver | 6 |
| Fibrosis | 5 |
| Digestive System Diseases | 2 |
| Liver Diseases | 2 |
| Metabolic Diseases | 2 |
| Fatty Liver, Alcoholic | 1 |
| Hepatic Encephalopathy | 1 |
| Hepatic Insufficiency | 1 |
| Infections | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.